Fasken Martineau DuMoulin LLP advised the Underwriter in connection with Medexus Pharmaceuticals’s offering. Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) closed its bought-deal public offering of 3,389,900…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Sonia Carcano
…
This content is for Standard 1 Year members only. LoginJoin Now